The estimated Net Worth of Steven A. Lisi is at least $4.68 Milion dollars as of 15 August 2024. Mr. Lisi owns over 50,000 units of Beyond Air stock worth over $685,891 and over the last 7 years he sold XAIR stock worth over $1,024,337. In addition, he makes $2,969,660 as Chairman of the Board i Chief Executive Officer at Beyond Air.
Steven has made over 21 trades of the Beyond Air stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 50,000 units of XAIR stock worth $18,500 on 15 August 2024.
The largest trade he's ever made was buying 190,437 units of Beyond Air stock on 12 December 2019 worth over $696,999. On average, Steven trades about 39,659 units every 79 days since 2018. As of 15 August 2024 he still owns at least 1,772,785 units of Beyond Air stock.
You can see the complete history of Mr. Lisi stock trades at the bottom of the page.
Steven A. Lisi serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. Lisi has served as our Chief Executive Officer since June 14, 2017. Mr. Lisi was previously Senior Vice President of Business and Corporate Development at Avadel Technologies (AVDL), where he was instrumental in restructuring the company and transforming it from $100,000,000 in enterprise value to $1 billion in three years. Mr. Lisi raised $121 million in equity, led the sale of Flamel’s contract manufacturing facility, rationalized the product pipeline, refocused the business development effort, transformed the investor base and established Flamel’s presence in Ireland. Prior to his position with Flamel, Mr. Lisi spent 18 years investing in healthcare companies on a global basis at Mehta and Isaly (now OrbiMed), SAC Capital (portfolio manager), Millennium Partners (portfolio manager), Panacea Asset Management (co-owner) and Deerfield Management (Partner). Mr. Lisi serves on the Board of Mico Innovations, a next generation coronary and neurovascular stent company and was formerly on the Board of Incysus Ltd, a transformational cell therapy company targeting solid tumors. Mr. Lisi received his Masters in International Business from Pepperdine University.
As the Chairman of the Board i Chief Executive Officer of Beyond Air, the total compensation of Steven Lisi at Beyond Air is $2,969,660. There are no executives at Beyond Air getting paid more.
Steven Lisi is 48, he's been the Chairman of the Board i Chief Executive Officer of Beyond Air since 2017. There are 9 older and 3 younger executives at Beyond Air. The oldest executive at Beyond Air, Inc. is Michael A. Gaul, 65, who is the Sr. VP of Operations.
Steven's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.
Over the last 5 years, insiders at Beyond Air have traded over $4,582,444 worth of Beyond Air stock and bought 3,519,117 units worth $12,396,434 . The most active insiders traders include Robert Carey, Steven A. Lisi oraz Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of $15,492. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth $18,500.
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Beyond Air executives and other stock owners filed with the SEC include: